244 related articles for article (PubMed ID: 34303953)
1. New therapeutic strategy: Personalization of pancreatic cancer treatment-irreversible electroporation (IRE), electrochemotherapy (ECT) and calcium electroporation (CaEP) - A pilot preclinical study.
Rudno-Rudzińska J; Kielan W; Guziński M; Płochocki M; Antończyk A; Kulbacka J
Surg Oncol; 2021 Sep; 38():101634. PubMed ID: 34303953
[TBL] [Abstract][Full Text] [Related]
2. Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation on quality of life and progression-free survival in patients with pancreatic cancer: IREC clinical study.
Rudno-Rudzińska J; Kielan W; Guziński M; Kulbacka J
Adv Clin Exp Med; 2021 Jul; 30(7):765-770. PubMed ID: 34313408
[TBL] [Abstract][Full Text] [Related]
3. Irreversible electroporation of locally advanced pancreatic cancer.
Kwon W; Thomas A; Kluger MD
Semin Oncol; 2021 Feb; 48(1):84-94. PubMed ID: 33648735
[TBL] [Abstract][Full Text] [Related]
4. Is irreversible electroporation safe and effective in the treatment of hepatobiliary and pancreatic cancers?
Wu LM; Zhang LL; Chen XH; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):117-124. PubMed ID: 30655073
[TBL] [Abstract][Full Text] [Related]
5. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
Martin RC; McFarland K; Ellis S; Velanovich V
J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results-a single-center experience.
Casadei R; Ricci C; Ingaldi C; Alberici L; Di Marco M; Guido A; Minni F; Serra C
Updates Surg; 2020 Dec; 72(4):1089-1096. PubMed ID: 32399592
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
[TBL] [Abstract][Full Text] [Related]
8. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
Marsanic P; Mellano A; Sottile A; De Simone M
Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
[TBL] [Abstract][Full Text] [Related]
9. Electroporation-based treatments in minimally invasive percutaneous, laparoscopy and endoscopy procedures for treatment of deep-seated tumors.
Granata V; Fusco R; D'Alessio V; Giannini A; Venanzio Setola S; Belli A; Palaia R; Petrillo A; Izzo F
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3536-3545. PubMed ID: 34002828
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy.
Månsson C; Brahmstaedt R; Nilsson A; Nygren P; Karlson BM
Eur J Surg Oncol; 2016 Sep; 42(9):1401-6. PubMed ID: 26906114
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
[TBL] [Abstract][Full Text] [Related]
12. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
[TBL] [Abstract][Full Text] [Related]
13. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
Martin RC; McFarland K; Ellis S; Velanovich V
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
[TBL] [Abstract][Full Text] [Related]
14. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
[TBL] [Abstract][Full Text] [Related]
15. Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience.
Lambert L; Horejs J; Krska Z; Hoskovec D; Petruzelka L; Krechler T; Kriz P; Briza J
Neoplasma; 2016; 63(2):269-73. PubMed ID: 26774149
[TBL] [Abstract][Full Text] [Related]
16. Investigation of safety for electrochemotherapy and irreversible electroporation ablation therapies in patients with cardiac pacemakers.
Jarm T; Krmac T; Magjarevic R; Kos B; Cindric H; Miklavcic D
Biomed Eng Online; 2020 Nov; 19(1):85. PubMed ID: 33198769
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous Irreversible Electroporation as First-line Treatment of Locally Advanced Pancreatic Cancer.
Månsson C; Brahmstaedt R; Nygren P; Nilsson A; Urdzik J; Karlson BM
Anticancer Res; 2019 May; 39(5):2509-2512. PubMed ID: 31092446
[TBL] [Abstract][Full Text] [Related]
18. Irreversible electroporation in locally advanced pancreatic cancer.
Polyakov AN; Patyutko YI; Kudashkin NE; Kantieva DM; Romanova KA; Nasonova EA; Korshak AV; Egenov OA; Podluzhnyi DV
Khirurgiia (Mosk); 2023; (10):29-38. PubMed ID: 37916555
[TBL] [Abstract][Full Text] [Related]
19. Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma.
Bhutiani N; Agle S; Li Y; Li S; Martin RC
J Surg Oncol; 2016 Aug; 114(2):181-6. PubMed ID: 27393627
[TBL] [Abstract][Full Text] [Related]
20. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
